Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Oct;26(1):67–77.

Cytophilic antibodies in bronchopulmonary aspergilloma and cryptogenic pulmonary eosinophilia.

E S Assem, M Turner-Warwick
PMCID: PMC1540820  PMID: 63346

Abstract

The immunoglobulin class and subclass of cytophilic antibodies have been studied using peripheral leucocytes from twenty-two patients with allergic bronchopulmonary aspergillosis, aspergilloma and cryptogenic pulmonary eosinophilia. In patients with allergic bronchopulmonary aspergillosis, significantly increased histamine liberation occurred following challenge of their leucocytes with antisera to IgE, IgG2, IgG3 and IgG4 as well as with Aspergillus fumigatus antigen. The results were considerably modified if the patient was receiving corticosteroids at the time of the test. The presence of IgG2-specific antibody to A. fumigatus in the serum of one patient, capable of sensitizing donor leucocytes, was demonstrated in passive sensitization experiments. In two patients with uncomplicated aspergillomas no evidence of cytophilic antibody to any class was found although large amounts of precipitating IgG antibody was present in the serum. Two patients with aspergilloma and systemic symptoms of weight loss and fatigue (which have been interpreted by others as 'hypersensitivity' responses) had increased amounts of cytophilic antibody similar to those with allergic bronchopulmonary aspergillosis. Six patients with cryptogenic pulmonary eosinophilia were also studied. No evidence of specific antibody to A. fumigatus was found but, as a group, significantly increased histamine liberation using antisera to IgG2 was demonstrated. Individual patients also showed evidence of other classes of cytophilic antibody, one having IgE, three IgG3 and two IgG4. The relationship between heat-stable short-term sensitizing antibody (IgG STS) inducing immediate skin responses and the pattern of cytophilic antibodies found in our patients with bronchopulmonary aspergillosis having dual (immediate and late reactions) is discussed. Clinically these tests are of diagnostic value and they may be helpful in assessing symptomatic patients with aspergillomas for corticosteroid treatment.

Full text

PDF
67

Images in this article

70Fig. 1
on p.70

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assem E. S., McAllen M. K. Serum reagins and leucocyte response in patients with house-dust mite allergy. Br Med J. 1970 May 30;2(5708):504–507. doi: 10.1136/bmj.2.5708.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Assem E. S., Schild H. O. Detection of allergy to penicillin and other antigens by in-vitro passive sensitization and histamine release from human and monkey lung. Br Med J. 1968 Aug 3;3(5613):272–276. doi: 10.1136/bmj.3.5613.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Assem E. S., Turner-Warwick M., Cole P., Shaw K. M. Reversed anaphylactic reaction of leucocytes in intrinsic asthma. Clin Allergy. 1971 Dec;1(4):353–361. doi: 10.1111/j.1365-2222.1971.tb00786.x. [DOI] [PubMed] [Google Scholar]
  4. Basten A., Beeson P. B. Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med. 1970 Jun 1;131(6):1288–1305. doi: 10.1084/jem.131.6.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Basten A., Boyer M. H., Beeson P. B. Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med. 1970 Jun 1;131(6):1271–1287. doi: 10.1084/jem.131.6.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bryant D. H., Burns M. W., Lazarus L. New type of allergic asthma due to IgG "reaginic" antibody. Br Med J. 1973 Dec 8;4(5892):589–592. doi: 10.1136/bmj.4.5892.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davies D., Somner A. R. Pulmonary aspergillomas treated with corticosteroids. Thorax. 1972 Mar;27(2):156–162. doi: 10.1136/thx.27.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dolovich J., Hargreave F. E., Chalmers R., Shier K. J., Gauldie J., Bienenstock J. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol. 1973 Jul;52(1):38–46. doi: 10.1016/0091-6749(73)90119-x. [DOI] [PubMed] [Google Scholar]
  9. Ishizaka T., Ishizaka K., Johansson S. G., Bennich H. Histamine release from human leukocytes by anti-gamma E antibodies. J Immunol. 1969 Apr;102(4):884–892. [PubMed] [Google Scholar]
  10. Lachmann P. J., Kay A. B., Thompson R. A. The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure. Immunology. 1970 Dec;19(6):895–899. [PMC free article] [PubMed] [Google Scholar]
  11. Malley A., Baecher L., Crossley G. The isolation of two humans IgG myeloma proteins with skin fixing properties on monkey lung tissue like human reagin. Int Arch Allergy Appl Immunol. 1973;45(1):26–29. doi: 10.1159/000230995. [DOI] [PubMed] [Google Scholar]
  12. McCarthy D. S., Pepys J. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin Allergy. 1971 Dec;1(4):415–432. doi: 10.1111/j.1365-2222.1971.tb00793.x. [DOI] [PubMed] [Google Scholar]
  13. McCarthy D. S., Pepys J. Cryptogenic pulmonary eosinophilias. Clin Allergy. 1973 Sep;3(3):339–351. doi: 10.1111/j.1365-2222.1973.tb01341.x. [DOI] [PubMed] [Google Scholar]
  14. Morell A., Skvaril F., Steinberg A. G., Van Loghem E., Terry W. D. Correlations between the concentrations of the four sub-classes of IgG and Gm Allotypes in normal human sera. J Immunol. 1972 Jan;108(1):195–206. [PubMed] [Google Scholar]
  15. Ovary Z., Kunkel H. G., Joslin F. G. Further studiesn guinea pig skin sensitizing activities of human myeloma proteins. J Immunol. 1970 Nov;105(5):1103–1107. [PubMed] [Google Scholar]
  16. Parish W. E. Detection of reagins, IgG, IgA and IgM antibodies in human sera. Int Arch Allergy Appl Immunol. 1969;36(3):245–265. doi: 10.1159/000230747. [DOI] [PubMed] [Google Scholar]
  17. Parish W. E. Short-term anaphylactic IgG antibodies in human sera. Lancet. 1970 Sep 19;2(7673):591–592. doi: 10.1016/s0140-6736(70)90170-4. [DOI] [PubMed] [Google Scholar]
  18. Patterson R., Fink J. N., Pruzansky J. J., Reed C., Roberts M., Slavin R., Zeiss C. R. Serum immunoglobulin levels in pulmonary allergic aspergillosis and certain other lung diseases, with special reference to immunoglobulin E. Am J Med. 1973 Jan;54(1):16–22. doi: 10.1016/0002-9343(73)90078-8. [DOI] [PubMed] [Google Scholar]
  19. Stanworth D. R., Smith A. K. Human IgG subclass with primate skin-binding activity. Lancet. 1972 Sep 2;2(7775):491–491. doi: 10.1016/s0140-6736(72)91890-9. [DOI] [PubMed] [Google Scholar]
  20. Turner-Warwick M., Assem E. S., Lockwood M. Cryptogenic pulmonary eosinophilia. Clin Allergy. 1976 Mar;6(2):135–145. doi: 10.1111/j.1365-2222.1976.tb01891.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES